Anixa Biosciences is trading 5.2% down at $2.91 amid a weaker September 8, 2026 market.
- The S&P 500 is down 0.59% and the Dow is down 1.18%, as rising oil prices, geopolitical tensions and cautious risk sentiment pressure equities broadly.
- No definitive company-specific announcement explains the decline.
- Anixa Biosciences is scheduled to present at the Nasdaq & LD Micro summit on September 9, but that upcoming event is not established as the cause.